glp-1 pfizer 2 Companies Poised to Capitalize on the Rise of Weight Loss Drugs Pfizer scraps daily weight loss

New code

A Phase-3 randomized clinical trial showed that the efficacy of HSK16149 capsules was superior to placebo in all groups for relieving PDPN and appeared well tolerated

Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia

For laboratories that need pharmaceutical-grade material at scale and can meet those requirements, Bachem sets a high manufacturing benchmark, which is why it appears near the top of this list despite limited accessibility

We really think this is just the tip of the iceberg. Treatment often involves managing the unpleasant side effects and discontinuing use of the substance

On December 15, 2025, the United States Judicial Panel on Multidistrict Litigation (JPML) announced a new multidistrict litigation (MDL) docket